CTA Community Poll: How Do Your Oncology News-Reading Habits Compare to Your Peers?
Around 30% of poll takers indicated that they read oncology news 3 to 4 times a week and almost 25% of our respondents indicated that they read oncology news every day.
Nearly 40% of our respondents indicated that they read more than 6 journal articles a week.
The <i>Journal of Clinical Oncology</i> was the go-to resource for journal articles for almost 28% of respondents, followed by the <i>New England Journal of Medicine</i>, <i>Lancet Oncology</i>, <i>Blood</i>, and <i>JAMA</i>, respectively.
The majority of respondents access their oncology news and information from their office or home computer (48.57%) or their laptop (24.29%).
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- CAR-T Trial for Triple-Negative Breast Cancer Under Way
- Daratumumab Combination: New Standard of Care in Transplant-Ineligible Multiple Myeloma
- Adjuvant Trastuzumab Emtansine Confers Improved Outcome in KATHERINE Trial
- Phase 3 GEICAM/CIBOMA Results: Adjuvant Capecitabine in Triple-Negative Breast Cancer
- Extension of Adjuvant Anastrozole Regimen to 10 Years Yields Higher DFS, but Not OS
- Molecular Mechanisms Underlying Immunosurveillance in Multiple Myeloma Identified
- Gly101Val Mutation Directly Causes Resistance to Venetoclax
- Can Treatments for Childhood ALL Alter the Gut Microbiome?
- Olaratumab May Be Safe and Effective in Patients With Advanced Soft Tissue Sarcoma
- Next-Generation Sequencing May Benefit Some Patients With Sarcoma